FDA Drug Application (203414) for KAZANO by TAKEDA PHARMS USA

Back to FDA Applications sponsored by TAKEDA PHARMS USA

Application Number203414
Product Number001
FormTABLET;ORAL
DosageEQ 12.5MG BASE;500MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameKAZANO
Active IngredientALOGLIPTIN BENZOATE; METFORMIN HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient ALOGLIPTIN BENZOATE3
List of drugs with Active Ingredient METFORMIN HYDROCHLORIDE32


Back to FDA Applications sponsored by TAKEDA PHARMS USA